The role of surgery in the management of gastrointestinal stromal tumors (GISTs) in the era of imatinib mesylate effectiveness

Surgical Oncology

Volumn 14, Issue 2, 2005, Pages 75-84

  Kosmadakis, Nikolaos ^a   Visvardis, Evangelos Efstathios ^a   Kartsaklis, Panagiotis ^a   Tsimara, Maria ^a   Chatziantoniou, Alexandros ^a   Panopoulos, Ioannis ^a   Erato, Palli ^a   Capsambelis, Paul ^a  

^a General Hospital of Zakynthos   (Greece)

Author keywords

c kit; Gastrointestinal stromal tumor; Gist; Glivec; Imatinib; Management; Mini review; Surgery

Indexed keywords

IMATINIB;

CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; DIARRHEA; ECZEMA; EDEMA; FATIGUE; GASTROINTESTINAL STROMAL TUMOR; HIGH RISK POPULATION; HUMAN; LIVER DYSFUNCTION; MYALGIA; PRIORITY JOURNAL; SHORT SURVEY; SURGICAL TECHNIQUE;

ANTINEOPLASTIC AGENTS; DIGESTIVE SYSTEM SURGICAL PROCEDURES; GASTROINTESTINAL STROMAL TUMORS; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; PYRIMIDINES;

EID: 23944518870     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2005.05.002     Document Type: Short Survey

References (73)

1. M. Miettinen, M. Sarlomo-Rikala, and J. Lasota Gastrointestinal stromal tumors: recent advances in understanding of their biology Human Pathology 30 1999 1213 1220
2. M.T. Mazur, and H.B. Clark Gastric stromal tumors Reappraisal of histogenesis. American Journal Surgical Pathology 7 6 1983 507 519
3. L.G. Kindblom, H.E. Remotti, F. Aldenborg, and J.M. Meis-Kindblom Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal American Journal Pathology 152 5 1998 1259 1269
4. M. Sarlomo-Rikala, A.J. Kovatich, A. Barusevicius, and M. Miettinen CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34 Modern Pathology 11 8 1998 728 734
5. I. Pidhorecky, R.T. Cheney, W.G. Kraybill, and J.F. Gibbs Gastrointestinal stromal tumors: current diagnosis, biologic behavior and management Annals of Surgical Oncology 7 9 2000 705 712
6. T. Nishida, S. Hirota, M. Taniguchi, K. Hashimoto, K. Isozaki, H. Nakamura, Y. Kanakura, T. Tanaka, A. Takabayashi, H. Matsuda, and Y. Kitamura Familial gastrointestinal tumors with germline mutation of kit gene Nature Genetics 19 4 1998 323 324
7. S. Hirota, K. Isozaki, Y. Moriyama, K. Hashimoto, T. Nishida, S. Ishiguro, K. Kawano, M. Hanada, A. Kurata, M. Takeda, G. Muhammad Tunio, Y. Matsuzawa, Y. Kanakura, Y. Shinomura, and Y. Kitamura Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors Science 279 5350 1998 577 580
8. C. Sturgeon, G. Chejfec, and N.J. Espat Gastrointestinal stromal tumors: a spectrum of disease Surgical Oncology 12 1 2003 21 26
9. M. Nakahara, K. Isozaki, S. Hirota, J. Miyagawa, N. Hase-Sawada, M. Taniguchi, T. Nishida, S. Kanayama, Y. Kitamura, Y. Shinomura, and Y. Matsuzawa A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors Gastroenterology 115 5 1998 1090 1095
10. M.L. Lux, B.P. Rubin, T.L. Biase, C.J. Chen, T. Maclure, G. Demetri, S. Xiao, S. Singer, C.D. Fletcher, and J.A. Fletcher KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors Amercian Journal of Pathol 156 3 2000 791 795
11. C.L. Corless, J.A. Fletcher, and M.C. Heinrich Biology of gastrointestinal stromal tumors Journal of Clinical Oncology 22 18 2004 3813 3825
12. B.J. Longley, M.J. Reguera, and Y. Ma Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy Leukemia Research 25 7 2001 571 576
13. J. Andersson, H. Sjogren, J.M. Meis-Kindblom, G. Stenman, P. Aman, and L.G. Kindblom The complexity of KIT gene mutations and chromosome rearrangements and their clinical correlation in gastrointestinal stromal (pacemaker cell) tumors American Journal of Pathology 160 1 2002 15 22
14. M.C. Heinrich, C.L. Corless, A. Duensing, L. McGreevey, C.J. Chen, N. Joseph, S. Singer, D.J. Griffith, A. Haley, A. Town, G.D. Demetri, C.D. Fletcher, and J.A. Fletcher PDGFRA activating mutations in gastrointestinal stromal tumors Science 299 5607 2003 708 710
15. R.P. DeMatteo, J.J. Lewis, D. Leung, S.S. Mudan, J.M. Woodruff, and M.F. Brennan Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival Annals of Surgery 231 1 2000 51 58
16. A.T. van Oosterom, I. Judson, J. Verweij, S. Stroobants, E. Donato di Paola, S. Dimitrijevic, M. Martens, A. Webb, R. Sciot, M. Van Glabbeke, S. Silberman, and O.S. Nielsen European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Safety and efficacy of imatinib (ST1571) in metastatic gastrointestinal stromal tumors: a phase I study. Lancet 358 9291 2001 1421 1423
17. C.R. Rossi, S. Mocellin, R. Mencarelli, M. Foletto, P. Pilati, D. Nitti, and M. Lise Gastrointestinal stromal tumors: from a surgical to a molecular approach International Journal of Cancer 107 2 2003 171 176
18. T. Nishida, and S. Hirota Biological and clinical review of stromal tumors in the gastrointestinal tract Histology and Histopathology 15 4 2000 1293 1301
19. R.P. DeMatteo The GIST of Targeted Cancer Therapy: A Tumor (Gastrointestinal Stromal Tumor), a Mutated Gene (c-kit), and a Molecular Inhibitor (ST1571) Annals Surgical of Oncology 9 9 2002 831 839
20. T. Nishida, S. Kumano, T. Sugiura, H. Ikushima, K. Nishikawa, T. Ito, and H. Matsuda Multidetector CT of high-risk patients with occult gastrointestinal stromal tumors American Journal of Rocentgenology 180 1 2003 185 189
21. G.J. Burkill, M. Badran, O. Al-Muderis, J. Meirion Thomas, I.R. Judson, C. Fisher, and E.C. Moskovic Malignant gastrointestinal stromal tumor: distribution, imaging features, and pattern of metastatic spread Radiology 226 2 2003 527 532
22. M.E. Robson, E. Glogowski, G. Sommer, C.R. Antonescu, K. Nafa, R.G. Maki, N. Ellis, P. Besmer, M. Brennan, and K. Offit Pleomorphic characteristics of a germ-line KIT mutation in a large kindred with gastrointestinal stromal tumors, hyperpigmentation, and dysphagia Clinical Cancer Research 10 4 2004 1250 1254
23. B.E. Plaat, H. Hollema, W.M. Molenaar, G.H. Torn Broers, J. Pijpe, M.F. Mastik, H.J. Hoekstra, E. van den Berg, R.J. Scheper, and W.T. van der Graaf Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins Journal of Clinical of Oncology 18 18 2000 3211 3220
24. G.D. Demetri, M. von Mehren, C.D. Blanke, A.D. Van den Abbeele, B. Eisenberg, P.J. Roberts, M.C. Heinrich, D.A. Tuveson, S. Singer, M. Janicek, J.A. Fletcher, S.G. Silverman, S.L. Silberman, R. Capdeville, B. Kiese, B. Peng, S. Dimitrijevic, B.J. Druker, C. Corless, C.D. Fletcher, and H. Joensuu Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors New England Journal Medicine 347 7 2002 472 480
25. S. Lau, K.F. Tam, C.K. Kam, C.Y. Lui, C.W. Siu, H.S. Lam, and K.L. Mak Imaging of gastrointestinal stromal tumour (GIST) Clinical Radiology 59 6 2004 487 498
26. A.D. Levy, H.E. Remotti, W.M. Thompson, L.H. Sobin, and M. Miettinen Gastrointestinal stromal tumors: radiologic features with pathologic correlation Radiographics 23 2 2003 283 304
27. A.D. Levy, H.E. Remotti, W.M. Thompson, L.H. Sobin, and M. Miettinen Anorectal Gastrointestinal Stromal Tumors: CT and MR Imaging Features with Clinical and Pathologic Correlation American Journal of Roentgenology 180 2003 1607 1612
28. B. Hughes, D. Yip, D. Goldstein, P. Waring, V. Beshay, and G. Chong Cerebral relapse of metastatic gastrointestinal stromal tumor during treatment with imatinib mesylate: case report BMC Cancer 4 1 2004 74
29. K.A. Yao, M.S. Talamonti, R.L. Langella, N.M. Schindler, S. Rao, W. Small Jr, and R.J. Joehl Primary gastrointestinal sarcomas: analysis of prognostic factors and results of surgical management Surgery 128 4 2000 604 612
30. J.H. Hwang, and M.B. Kimmey The incidental upper gastrointestinal subepithelial mass Gastroenterology 126 1 2004 301 307
31. J.P. Pierie, U. Choudry, A. Muzikansky, B.Y. Yeap, W.W. Souba, and M.J. Ott The effect of surgery and grade on outcome of gastrointestinal stromal tumors Archives of Surgery 136 4 2001 383 389
32. S.J. Kwon Korean Gastric Cancer Study Group Surgery and prognostic factors for gastric stromal tumor. World Journal of Surgery 25 3 2001 290 295
33. James R Howe, Lucy H Karnell, and C Scott-Conner. Small Bowel Sarcoma: analysis of survival from the national cancer data base. Annals of Surgical Oncology 2001;8(6):496-08.
34. C.D. Fletcher, J.J. Berman, C. Corless, F. Gorstein, J. Lasota, B.J. Longley, M. Miettinen, T.J. O'Leary, H. Remotti, B.P. Rubin, B. Shmookler, L.H. Sobin, and S.W. Weiss Diagnosis of gastrointestinal stromal tumors: A consensus approach Human Pathology 33 5 2002 459 465
35. H. Yan, P. Marchettini, Y.I. Acherman, S.A. Gething, E. Brun, and P.H. Sugarbaker Prognostic assessment of gastrointestinal stromal tumor American Journal of Clinical Oncology 26 3 2003 221 228
36. T.S. Emory, L.H. Sobin, L. Lukes, D. Lee, and T.J. O'Leary Prognosis of gastrointestinal smooth-muscle(stromal) tumors: dependence on anatomic site American Journal of Surgical Pathology 23 1 1999 82 87
37. Bucher P, Taylor S, Villiger P, Morel P, Brundler MA. Are there any prognostic factors for small intestinal stromal tumors? American Journal of Surgery 2004;187(6):761-6.
38. B.M. Clary, R.P. DeMatteo, J.J. Lewis, D. Leung, and M.F. Brennan Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum: a clinical comparison Annals of Surgical Oncology 8 4 2001 290 299
39. E.H. Ng, R.E. Pollock, M.F. Munsell, E.N. Atkinson, and M.M. Romsdahl Prognostic factors influencing survival in gastrointestinal leiomyosarcomas: implications for surgical management and staging Annals of Surgery 215 1 1992 68 77
40. J.A. Crosby, C.N. Catton, A. Davis, J. Couture, B. O'Sullivan, R. Kandel, and C.J. Swallow Malignant Gastrointestinal Stromal Tumors of the small intestine: a review of 50 cases from a prospective database Annals of Surgical Oncology 8 1 2001 50 59
41. C. Langer, B. Gunawan, P. Schuler, W. Huber, L. Fuzesi, and H. Becker Prognostic factors influencing surgical management and outcome of gastrointestinal stromal tumours British Journal of Surgery 90 3 2003 332 339
42. S. Mudan, K.C. Conlon, M. Woodruff, J. Lewis, and M.F. Brennan Salvage surgery for patients with recurrent Gastrointestinal sarcoma Cancer 88 1 2000 66 74
43. E.H. Ng, R.E. Pollock, and M.M. Romsdahl Prognostic implications of patterns of failure for gastrointestinal leiomyosarcomas Cancer 69 6 1992 1334 1341
44. R.P. DeMatteo, A. Shah, Y. Fong, W.R. Jarnagin, L.H. Blumgart, and M.F. Brennan Results of hepatic resection for sarcoma metastatic to liver Annals of Surgery 234 4 2001 540 548
45. H. Lang, K.T. Nussbaum, P. Kaudel, N. Fruhauf, P. Flemming, and R. Raab Hepatic metastases from leiomyosarcoma: a single-center experience with 34 liver resections during a 15-year period Annals of Surgery 231 4 2000 500 505
46. S.R. Patel, and R.S. Benjamin Management of peritoneal and hepatic metastases from gastrointestinal stromal tumors Surgical of Oncology 9 2 2000 67 70
47. D.A. Tuveson, N.A. Willis, T. Jacks, J.D. Griffin, S. Singer, C.D. Fletcher, J.A. Fletcher, and G.D. Demetri STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications Oncogene 20 36 2001 5054 5058
48. H. Joensuu, P.J. Roberts, and M. Sarlomo-Rikala Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor New England Journal of Medicine 344 2001 1052 1056
49. B.L. Eisenberg, and M. von Mehren Pharmacotherapy of gastrointestinal stromal tumours Expert Opinion on Pharmacotherapy 4 6 2003 869 874
50. C.D. Blanke, B.L. Eisenberg, and M.C. Heinrich Gastrointestinal stromal tumors Current Treatment Options in Oncology 2 6 2001 485 491
51. M. Debiec-Rychter, H. Dumez, I. Judson, B. Wasag, J. Verweij, M. Brown, S. Dimitrijevic, R. Sciot, M. Stul, H. Vranck, M. Scurr, A. Hagemeijer, M. van Glabbeke, and A.T. van Oosterom EORTC Soft Tissue and Bone Sarcoma Group Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group. European Journal of Cancer 40 5 2004 689 695
52. Demetri GD. Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571). European Journal of Cancer 2002 Sep;38 Suppl 5:S52-9.
53. I. Judson, P. Ma, B. Peng, J. Verweij, A. Racine, E.D. di Paola, M. van Glabbeke, S. Dimitrijevic, M. Scurr, H. Dumez, and A. van Oosterom Imatinib pharmacokinetics in patients with gastrointestinal stromal tumour: a retrospective population pharmacokinetic study over time EORTC Soft Tissue and Bone Sarcoma Group. Cancer Chemotheropy and Pharmacology 55 4 2005 379 386
54. J. Verweij, P.G. Casali, J. Zalcberg, A. LeCesne, P. Reichardt, J.Y. Blay, R. Issels, A. van Oosterom, P.C. Hogendoorn, M. Van Glabbeke, R. Bertulli, and I. Judson Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial Lancet 364 9440 2004 1127 1134
55. G.D. Demetri Targeting the molecular pathophysiology of gastrointestinal stromal tumors with imatinib Mechanisms, successes, and challenges to rational drug development. Hematology Oncology Clinics of North America 16 5 2002 1115 1124
56. R.G. Maki Gastrointestinal Stromal Tumors Respond to Tyrosine Kinase-targeted Therapy Current Treatment Options in Gastroenterology 7 1 2004 13 17
57. P. Bumming, J. Andersson, J.M. Meis-Kindblom, H. Klingenstierna, K. Engstrom, U. Stierner, B. Wangberg, S. Jansson, H. Ahlman, L.G. Kindblom, and B. Nilsson Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients British Journal of Cancer 89 3 2003 460 464
58. M.C. Heinrich, C.L. Corless, G.D. Demetri, C.D. Blanke, M. von Mehren, H. Joensuu, L.S. McGreevey, C.J. Chen, A.D. Van den Abbeele, B.J. Druker, B. Kiese, B. Eisenberg, P.J. Roberts, S. Singer, C.D. Fletcher, S. Silberman, S. Dimitrijevic, and J.A. Fletcher Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor Journal of Clinical Oncology 21 23 2003 4342 4349
59. S. Bauer, C.L. Corless, M.C. Heinrich, O. Dirsch, G. Antoch, J. Kanja, S. Seeber, and J. Schutte Response to imatinib mesylate of a gastrointestinal stromal tumor with very low expression of KIT Cancer Chemotherapy and Pharmacology 51 3 2003 261 265
60. M. Miettinen, L.H. Sobin, and J. Lasota Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up American Journal of Surgical Pathology 29 1 2005 52 68
61. M. Yamaguchi, T. Matsumoto, G. Tate, and T. Higuchi Secondary resistance to imatinib mesylate in a patient with unresectable duodenal GIST without mutations in exons 9, 11, 13, or 17 of the c-kit protooncogene Journal of Gastroenterology 39 9 2004 904 905
62. E. Tamborini, L. Bonadiman, A. Greco, V. Albertini, T. Negri, A. Gronchi, R. Bertulli, M. Colecchia, P.G. Casali, M.A. Pierotti, and S. Pilotti A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient Gastroenterology 127 1 2004 294 299
63. J. Lasota, A. Wozniak, J. Kopczynski, A. Dansonka-Mieszkowska, B. Wasag, T. Mitsuhashi, M. Sarlomo-Rikala, J.R. Lee, R. Schneider-Stock, J. Stachura, J. Limon, and M. Miettinen Loss of heterozygosity on chromosome 22q in gastrointestinal stromal tumors (GISTs): a study on 50 cases Laboratory Investigation 85 2 2005 237 247
64. S. Stroobants, J. Goeminne, M. Seegers, S. Dimitrijevic, P. Dupont, J. Nuyts, M. Martens, B. van den Borne, P. Cole, R. Sciot, H. Dumez, S. Silberman, L. Mortelmans, and A. van Oosterom 18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec) European Journal of Cancer 39 14 2003 2012 2020
65. H. Choi, C. Charnsangavej, S. de Castro Faria, E.P. Tamm, R.S. Benjamin, M.M. Johnson, H.A. Macapinlac, and D.A. Podoloff CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings American Journal of Roentgenology 183 6 2004 1619 1628
66. K.M. Horton, K. Juluru, E. Montogomery, and E.K. Fishman Computed tomography imaging of gastrointestinal stromal tumors with pathology correlation Journal Computer of Assisted Tomography 28 6 2004 811 817
67. J. Pollock, D. Morgan, J. Denobile, and J. Williams Adjuvant radiotherapy for gastrointestinal stromal tumor of the rectum Digestive Disease and Sciences 46 2 2001 268 272
68. R. Garcia-Carbonero, J.G. Supko, J. Manola, M.V. Seiden, D. Harmon, D.P. Ryan, M.T. Quigley, P. Merriam, J. Canniff, G. Goss, U. Matulonis, R.G. Maki, T. Lopez, T.A. Puchalski, M.A. Sancho, J. Gomez, C. Guzman, J. Jimeno, and G.D. Demetri Phase II and pharmacokinetic study of ecteinascidin 743 in patients with progressive sarcomas of soft tissues refractory to chemotherapy Journal of Clinical Oncology 22 8 2004 1480 1490
69. B. Berthet, T.A. Sugarbaker, D. Chang, and P.H. Sugarbaker Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment European Journal of Cancer 35 3 1999 413 419
70. F.C. Eilber, G. Rosen, C. Forscher, S.D. Nelson, F. Dorey, and F.R. Eilber Recurrent gastrointestinal stromal sarcomas Surgical Oncology 9 2 2000 71 75
71. F.C. Eilber, G. Rosen, C. Forscher, S. Nelson, F. Dorey, and F.R. Eilber Surgical resection and intraperitoneal chemotherapy for recurrent abdominal sarcomas Annals of Surgical Oncology 6 7 1999 645 650
72. G.M. Mavligit, A.A. Zukwiski, L.M. Ellis, V.P. Chuang, and S. Wallace Gastrointestinal leiomyosarcoma metastatic to the liver Durable tumor regression by hepatic chemoembolization infusion with cisplatin and vinblastine. Cancer 75 8 1995 2083 2088
73. D.K. Rajan, M.C. Soulen, T.W. Clark, R.A. Baum, Z.J. Haskal, R.D. Shlansky-Goldberg, and D.B. Freiman Sarcomas metastatic to the liver: response and survival after cisplatin, doxorubicin, mitomycin-C, Ethiodol, and polyvinyl alcohol chemoembolization Journal of Vascular and Interventional Radiology 12 2 2001 187 193